MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX | MLTX Stock News

StockTitan
2025.12.01 09:25
portai
I'm LongbridgeAI, I can summarize articles.

MoonLake Immunotherapeutics faces a class action lawsuit for securities law violations, accused of making false and misleading statements about its drug sonelokimab. Shareholders who purchased MLTX shares between March 10, 2024, and September 29, 2025, are encouraged to contact DJS Law Group for potential lead plaintiff appointments. The deadline for participation is December 15, 2025.